Coronary Drug Project

CDP (1980) Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 303 1038-1041... [Pg.117]

Byar DP (1980) Why data bases should not replace randomised trials Biometrics, 36, 337-342 Campbell MJ, Donner A and Klar N (2007) Developments in cluster randomised trials and Statistics in Medicine Statistics in Medicine, 26, 2-19 Coronary Drug Project Research Group (1980) Influence and adherence to treatment and response of cholesterol on mortality in the coronary drug project New England Journal of Medicine, 303, 1038-1041... [Pg.261]

The Coronary Drug Project in men taking different doses of estrogens showed a dose-related increase in myocardial infarction and thromboembolic diseases (15). [Pg.175]

Coronary Drug Project. Gallbladder disease as a side effect of drugs influencing lipid metabohsm. N Engl J Med 1977 296(21) 1185-90. [Pg.248]

In the US Coronary Drug Project (23) a formulation of dextrothyroxine with a so-called low levothyroxine content was used. The study had to be terminated because of an excessive number of cardiac deaths and non-fatal infarcts. [Pg.348]

The Coronary Drug Project Research Group. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. JAMA 1972 220(7) 996-1008. [Pg.353]

Report on the coronary drug project research group, Clofibrate and niacin in coronary heart disease. JAMA 231 360-380, 1975. [Pg.317]

C18. Coronary Drug Project Research Group. The Coronary Drug Project Initial findings leading to modification of its research protocol. J. Am. Med. Assoc. 214, 1303—1313 (1970). [Pg.273]

Coronary Drug Project Research Group (1980). Influence of adherence to treatment and response to cholesterol on mortality in the Coronary Drug Project. New England Journal of Medicine 303 1038-1041 Dahlof B, Lindholm LH, Hansson L etal. (1991). Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Lancet 338 1281-1285 Davis KL, Thai LJ, Gamzu ER et al. (1992). [Pg.237]

Canner PL, Furberg CD, Terrin ML, McGovern ME (2005) Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project). Am J Cardiol 95 254-257... [Pg.290]

The recent completion of the Coronary Drug Project, a secondary prevention trial in men with a proven previous myocardial infarction, failed to show an effect for nicotinic acid or clofibrate on either plasma cholesterol levels or mortality.16 A primary prevention trial of cholestyramine resin in Type II hyperlipoprotelnemic men is in progress.17 Hypolipidemic agents which are more effective than nicotinic acid and clofibrate are... [Pg.191]

Table 7.11 Some results from Coronary Drug Project relating to compliance...

Canner PL, Berge KG, Wenger NK, et al. Fifteen-year mortality in Coronary Drug Project patients Long-term benefit with niacin. J Am Coll Cardiol 1986 8 1245-1255. [Pg.452]

In a long-term follow-up of the Coronary Drug Project, Canner et al. (54) found in 8,341 men with established CHD that treatment with niacin resulted in an 11% relative risk reduction for mortality compared with placebo. Interestingly, despite beneficial effects on HDL cholesterol levels, treatment with estrogen was halted early in this trial for an increase in adverse effects and outcomes (55). [Pg.72]

Coronary Drug Project. Findings leading to discontinuation... [Pg.80]

Stamler J. The coronary drug project— findings with regard to estrogen, dextro-thyroxine, clofibrate and niacin. Adv Exp Med Biol 1977 82 52-75. [Pg.682]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...